MLANA-loaded nanoparticle vaccine plus mAbs against PD-1 and OX40 to sensitize melanoma to Imbruvica

DISEASE CATEGORY: Cancer

INDICATION: Melanoma

Immunization with an MLANA-loaded nanoparticle vaccine in combination with mAbs against PD-1 and OX40 could

Read the full 185 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE